Src family kinases differentially influence glioma growth and motility-Reference-Cited by-同舟云学术

Src family kinases differentially influence glioma growth and motility

Published:2015-06-10 Issue:9 Volume:9 Page:1783-1798
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Lewis-Tuffin Laura J.,Feathers Ryan,Hari Priya,Durand Nisha,Li Zhimin,Rodriguez Fausto J.,Bakken Katie,Carlson Brett,Schroeder Mark,Sarkaria Jann N.,Anastasiadis Panos Z.

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2015.06.001/fullpdf

Reference50 articles.

1. The non-receptor tyrosine kinase Lyn is localised in the developing murine blood-brain barrier;Achen;Differentiation,1995

2. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies;Ahluwalia;Cancer Lett.,2010

3. SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions;Angers-Loustau;Mol. Cancer Res.,2004

4. Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery;Carlson;Curr. Protoc. Pharmacol.,2011

5. Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development;Colognato;J. Cell Biol,2004

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of LYN Is Frequent in Targeted Therapy–Resistant Melanoma Cells and Favors Metastatic Properties;Journal of Investigative Dermatology;2024-07

2. EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma;International Journal of Molecular Sciences;2024-06-06

3. GD3 ganglioside is a promising therapeutic target for glioma patients.;Neuro-Oncology Advances;2024-01-01

4. A renaissance for YES in cancer;Oncogene;2023-10-17

5. Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities;Cells;2023-08-30